» Articles » PMID: 36141242

Interventions and Impact of Pharmacist-Delivered Services for People Infected with COVID-19: A Systematic Review

Overview
Specialty Health Services
Date 2022 Sep 23
PMID 36141242
Authors
Affiliations
Soon will be listed here.
Abstract

Pharmacists are essential members of the healthcare team. The emergence of the novel coronavirus disease 2019 (COVID-19) pandemic has led pharmacists to undertake additional clinical roles. We aim to conduct a systematic review on the interventions and impact of pharmacist-delivered services in managing COVID-19 patients. We searched PubMed, Embase, Scopus, CINAHL plus, International Pharmaceutical Abstracts, and Web of Science from 1 December 2019 (the first case of COVID-19 emerged) to 13 January 2022 to retrieve the articles. Cochrane handbook and PRISMA guidelines were followed respectively to perform and report the review. The pharmacist-led interventions were reported following the Descriptive Elements of Pharmacist Intervention Characterization Tool (DEPICT) version 2. The protocol of systematic review was registered on PROSPERO (CRD42021277128). Studies quality was assessed with the modified NOS scale. In total, 7 observational studies were identified from 10,838 studies. Identification of dosage errors ( = 6 studies), regimen modifications ( = 5), removal of obsolete/duplicate medications ( = 5), identification and management of adverse drug reactions ( = 4), drug interactions prevention ( = 2), and physicians acceptance rate ( = 3) of therapy-related services delivered in-person or via tele-pharmacy were among the pharmacist-delivered services. Common interventions delivered by pharmacists also included optimizing the use of antibacterial, antivirals, and anticoagulants in COVID-19 infected patients. The acceptance of pharmacist-delivered services by physicians was high (88.5-95.5%). Included studies have described pharmacists' beneficial role in managing patients with COVID-19 including detection, resolution, and prevention of medication-related problems, with physicians demonstrating high trust in pharmacists' advice. Future research should assess the feasibility and scalability of such roles in real-world settings.

Citing Articles

The role of pharmacists in mitigating medication errors in the perioperative setting: a systematic review.

Naseralallah L, Koraysh S, Alasmar M, Aboujabal B Syst Rev. 2025; 14(1):12.

PMID: 39810205 PMC: 11731391. DOI: 10.1186/s13643-024-02710-1.


Interventions and impact of pharmacist-delivered services in perioperative setting on clinically important outcomes: a systematic review and meta-analysis.

Naseralallah L, Koraysh S, Aboujabal B, Alasmar M Ther Adv Drug Saf. 2024; 15:20420986241260169.

PMID: 39091467 PMC: 11292727. DOI: 10.1177/20420986241260169.


Telepharmacy Implementation to Support Pharmaceutical Care Services during the COVID-19 Pandemic: A Scoping Review.

Sarasmita M, Sudarma I, Jaya M, Irham L, Susanty S Can J Hosp Pharm. 2024; 77(1):e3430.

PMID: 38204502 PMC: 10754407. DOI: 10.4212/cjhp.3430.


Disaster Preparedness Amongst Emergency Pharmacists for the FIFA World Cup Qatar 2022™: A Cross-Sectional Survey.

Isleem N, Naseralallah L, Koraysh S, Abu Ghalyoun A, Alnaimi S, Pallivalapila A Risk Manag Healthc Policy. 2023; 16:573-583.

PMID: 37038373 PMC: 10082576. DOI: 10.2147/RMHP.S404367.


Analysis of Pharmacy Cardiac Optimization Clinic for Patients with New Onset Atrial Fibrillation Detected via Cardiac Implantable Electronic Device Clinic.

Schellhase E, Stanko M, Kinstler N, Miller M, Antoniou S, Fhadil S Pharmacy (Basel). 2023; 11(2).

PMID: 36961026 PMC: 10037589. DOI: 10.3390/pharmacy11020048.


References
1.
Nadeem M, Samanta S, Mustafa F . Is the paradigm of community pharmacy practice expected to shift due to COVID-19?. Res Social Adm Pharm. 2020; 17(1):2046-2048. PMC: 7255229. DOI: 10.1016/j.sapharm.2020.05.021. View

2.
Shah M, Simon Sumeh A, Sheraz M, Kavitha M, Venmathi Maran B, Rodrigues K . A mini-review on the impact of COVID 19 on vital organs. Biomed Pharmacother. 2021; 143:112158. PMC: 8416601. DOI: 10.1016/j.biopha.2021.112158. View

3.
Perez M, Masse M, Deldicque A, Beuscart J, de Groote P, Desbordes J . Analysis of clinical pharmacist interventions in the COVID-19 units of a French university hospital. Eur J Hosp Pharm. 2021; 29(e1):e30-e35. PMC: 7956730. DOI: 10.1136/ejhpharm-2020-002542. View

4.
San-Juan-Rodriguez A, Newman T, Hernandez I, Swart E, Klein-Fedyshin M, Shrank W . Impact of community pharmacist-provided preventive services on clinical, utilization, and economic outcomes: An umbrella review. Prev Med. 2018; 115:145-155. DOI: 10.1016/j.ypmed.2018.08.029. View

5.
Tan S, Zhang B, Xu P . Chinese pharmacists' rapid response to the COVID-19 outbreak. Am J Health Syst Pharm. 2020; 77(14):1096-1097. PMC: 7239245. DOI: 10.1093/ajhp/zxaa120. View